CLOVIS ONCOLOGY INC CLVS
COM · Common Stock · CUSIP 189464100 · ISIN US1894641000
0
institutional holders
-2 vs Q1 2023
—reported value*
0 new
0 added
0 reduced
2 sold out
net sold ≈ $520.2k (-36.8k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 103 |
| Q4 2022 | 14 |
| Q1 2023 | 2 |
| Q2 2023 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 2 | 92 |
| Q1 2023 | 1 | 12 |
| Q2 2023 | 0 | 2 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2022 | $5.0m | $2.1m | 0.42 |
| Q4 2022 | $22.0k | $0 | 0.00 |
| Q1 2023 | $0 | $0 | — |
| Q2 2023 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| MAI Capital Management | Sold out | -20.0k |
| RESOURCES MANAGEMENT CORP /CT/ /ADV | Sold out | -16.8k |
Holders, Q2 2023
| Manager | Shares | Change |
|---|